View Item 

Show simple item record

Covariation of depressive symptoms, parkinsonism, and post-dexamethasone plasma cortisol levels in a bipolar patient: simultaneous response to ECT and lithium carbonate
dc.contributor.authorJaeckle, Richard S.en_US
dc.contributor.authorDilsaver, Steven C.en_US
dc.date.accessioned2010-04-01T15:42:43Z
dc.date.available2010-04-01T15:42:43Z
dc.date.issued1986-07en_US
dc.identifier.citationJaeckle, R. S.; Dilsaver, S. C. (1986). "Covariation of depressive symptoms, parkinsonism, and post-dexamethasone plasma cortisol levels in a bipolar patient: simultaneous response to ECT and lithium carbonate." Acta Psychiatrica Scandinavica 74(1): 68-72. <http://hdl.handle.net/2027.42/66202>en_US
dc.identifier.issn0001-690Xen_US
dc.identifier.issn1600-0447en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/66202
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2876588&dopt=citationen_US
dc.description.abstract: A patient presented with concurrent mood congruent delusions, parkinsonism, and elevated post-dexamethasone plasma cortisol levels. This triad could result from simultaneous development of cholinergic-monoaminergic dysfunction within critical limbic and extrapyramidal loci. The magnitude of each abnormality decreased in concert during a course of electroconvulsive therapy (ECT). Remaining abnormalities disappeared during treatment with lithium. Actions of ECT and lithium on muscarinic systems are reviewed, and a strategy for testing the hypothesis that dysfunction of cholinergic-monoaminergic mechanisms develops in parallel in different neural networks is considered.en_US
dc.format.extent396267 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1986 Blackwell Publishing Ltden_US
dc.subject.otherBipolaren_US
dc.subject.otherCholinergicen_US
dc.subject.otherDepressionen_US
dc.subject.otherElectroconvulsive Therapyen_US
dc.subject.otherLithiumen_US
dc.titleCovariation of depressive symptoms, parkinsonism, and post-dexamethasone plasma cortisol levels in a bipolar patient: simultaneous response to ECT and lithium carbonateen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Iowa, Psychiatric Hospital, and University of Michigan, Dept. of Psychiatry, Ann Arbor, U.S.A.en_US
dc.identifier.pmid2876588en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/66202/1/j.1600-0447.1986.tb06229.x.pdf
dc.identifier.doi10.1111/j.1600-0447.1986.tb06229.xen_US
dc.identifier.sourceActa Psychiatrica Scandinavicaen_US
dc.identifier.citedreferenceMindham R H S. Psychiatric symptoms in parkinsonism. J Neurol Neurosurg Psychiatry 1970 : 33 : 188.en_US
dc.identifier.citedreferenceHorne S. Some psychological factors in parkinsonism. J Neurol Neurosurg Psychiatry 1974 : 37 : 27 – 31.en_US
dc.identifier.citedreferenceSpitzer R L, Endicott J., Robbins E. Research Diagnostic Criteria. 2nd ed., New York State Department of Mental Hygiene, New York Psychiatric Institute. Biometrics Research, 1975.en_US
dc.identifier.citedreference5. Diagnostic and Statistical Manual of the American Psychiatric Association, 3rd ed., Washington, D.C., 1980.en_US
dc.identifier.citedreferenceHamilton M. A Rating Scale for Depression. J Neurol Neurosurg Psychiatry 1962 : 23 : 56 – 62.en_US
dc.identifier.citedreferenceBlessed G., Tomlinson B E, Roth M. The association between quantitative measures of dementia and senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968 : 114 : 797 – 811.en_US
dc.identifier.citedreferenceCarroll B J, Feiberg M., Greden J F, et al. A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 1981 : 38 : 15 – 22.en_US
dc.identifier.citedreferenceGrunhaus L., Dilsaver S C, Greden J F, Carroll B J. Depressive pseudodementia: A suggested diagnostic profile. Biol Psychiatry 1983 : 18 : 215 – 225.en_US
dc.identifier.citedreferenceHornykiewicz O. Brain neurotransmitters in Parkinson's disease. In : Marsden C D, Fahn S., eds. Movement disorders. London : B. Herworths, 1982 : 41 – 58.en_US
dc.identifier.citedreferencevan Praag H M, Korf J. Retarded depression in the dopamine metabolism. Psychophamacology 1971 : 18 : 199 – 203.en_US
dc.identifier.citedreferencePenny J B, Young A B. Speculations on the functional anatomy of basal ganglia disorders. Ann Rev Neurosci 1983 : 6 : 73 – 94.en_US
dc.identifier.citedreferencevan Praag H M. Depression, suicide and serotonin metabolism of the brain. In : Post R M, Ballenger J C, eds. The neurobiology of manic-depressive illness. Baltimore : Williams and Wilkins, 1971.en_US
dc.identifier.citedreferenceGoodwin F K, Potter W Z. Noradrenergic function in affective illness. In : Saletu B., Berner P., Holister L., eds. Neuropsychopharmacology. New York : Pergamon Press, 1979 : 127 – 137.en_US
dc.identifier.citedreferenceCharney D S, Menkes D B, Heninger G R. Receptor sensitivity in the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 1981 : 38 : 1160 – 1180.en_US
dc.identifier.citedreferenceVizi E S, Pasztor E. Relase of acetylcholine from isolated human cortical slices: inhibitory effect of norepinephrine and phenytoin. Exp Neurol 1981 : 73 : 144 – 153.en_US
dc.identifier.citedreferenceDilsaver S C, Greden J F. Activation on antidepressant withdrawal: A possible mechanism and its theoretical significance. Brain Res Rev 1984 : 7 : 29 – 48.en_US
dc.identifier.citedreferenceDilsaver S C. Pathophysiology of cholinoceptor supersensitivity in affective disorders. Biol Psychiatry ( in press 1986 ).en_US
dc.identifier.citedreferenceJanowsky D S, Risch S C, Huey L Y, Judd L., Raush J L. Hypothalamic-pituitary-adrenal regulation: Neurotransmitters and affective disorders. Peptides 1983 : 4 : 775 – 784.en_US
dc.identifier.citedreferenceCarroll B J. Greden J F, Haskett R., et al. Neurotransmitter studies of neuroendocrine pathology in depression. Acta Psychiatr Scand 1980 : 61, Suppl 280 : 183 – 199.en_US
dc.identifier.citedreferenceDoerr P. Berger M. Physostigmine-induced escape from dexamethasone in normal subjects. Biol Psychiatry 1983 : 18 : 216 – 268.en_US
dc.identifier.citedreferenceRisch S C, Janowsky D S, Gillin J C. Muscarinic supersensitivity of anterior pituitary ACTH and beta-endorphin release in major depressive illness. Peptides 1983 : 4 : 789 – 792.en_US
dc.identifier.citedreferenceRisch S C. Β-endorphin hypersecretion in depression: Possible cholinergic mechanisms. Biol Psychiatry 1982 : 17 : 1071 – 1079.en_US
dc.identifier.citedreferenceHolcomb H H, Stenberg A E, Heninger G R. Effect of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems. Biol Psychiatry 1983 : 18 : 865 – 873.en_US
dc.identifier.citedreferenceChido L A, Antelman S M. Electroconvulsive shock, progressive dopamine autoreceptor subsensitivity independent of repeated treatment. Science 1980 : 17 : 210 – 799.en_US
dc.identifier.citedreferenceLerer B., Belmaker R H. Receptors and the mechanism of action of ECT. Biol Psychiatry 1982 : 17 : 497 – 511.en_US
dc.identifier.citedreferenceLieberman A., Glofaghari M., Boal D. et al. The anti-parkinsonian efficacy of bromocriptine. Neurology 1976 : 26 : 405 – 409.en_US
dc.identifier.citedreferenceMarsden C D, Parkes J D. Success and problems of long-term levo-dopa therapy in Parkinson's disease. Lancet 1977 : 2 : 345 – 349.en_US
dc.identifier.citedreferenceSchwab R S, England A C, Poskanzer D C, Young R R. Amantadine in the treatment of Parkinson's disease. J Am Med Assoc 1969 : 208 : 1168 – 1170.en_US
dc.identifier.citedreferenceBirkmeyer W., Riederer P., Ambrozi L., Yodim M B H. Implication of combined treatment with “Modapar” and L-deprenyl in Parkinson's disease. Lancet : 1 : 439 – 440.en_US
dc.identifier.citedreferenceKnoll J. The possible mechanisms of action of (-)deprenyl in Parkinson's disease. J Neural Transm 1978 : 43 : 177 – 198.en_US
dc.identifier.citedreferenceYahr M D. A review of present day treatment of Parkinson's disease. J Neural Transm 1978 : 43 : 79 – 84.en_US
dc.identifier.citedreferenceBianchine J R. Drugs for Parkinson's disease. In : Gilman A G, Goodman L S, Gilman A., eds. 6th ed. The pharmacological basis of therapeutics. New York : Macmillan, 1980 : 484.en_US
dc.identifier.citedreferenceHimwich H E, Alpers H S. Psychopharmacology. An Rev Pharmacol 1970 : 10 : 313.en_US
dc.identifier.citedreferenceFuxe K., et al. Chronic antidepressant treatment in central 5-HT synapses. Neuropharmacology 1983 : 22 : 389 – 400.en_US
dc.identifier.citedreferenceDasheiff R M, Byrne M C, Patroni U., McNamara J O. Biochemical evidence of decreased cholinergic neuronal communication following amygdala kindled seizures. Brain Res 1981 : 206 : 233 – 238.en_US
dc.identifier.citedreferenceDasheiff R M, Savage D D, McNamara J O. Seizures down-regulate muscarinic cholinergic receptors in hippo-campal formation. Brain Res 1982 : 235 : 327 – 334.en_US
dc.identifier.citedreferenceDasheiff R J, McNamara J O. Evidence for an anonist independent down-regulation of hippocampal muscarinic receptors in kindling. Brain Res 1980 : 195 : 345 – 353.en_US
dc.identifier.citedreferencePestronk A., Drachman D B. Lithium reduces the number of acetylcholine receptors in skeletal muscle. Science 1980 : 210 : 342.en_US
dc.identifier.citedreferenceByrne M C, Gottlieb N., McNamara T O. Amygdala kindling induces muscarinic cholinergic receptor declines in a highly specific distribution within the limbic system. Symp Neurol 1980 : 69 : 85 – 98.en_US
dc.identifier.citedreferenceDilsaver S C. Effects of lithium on muscarinic receptor binding parameters: A relationship to therapeutic efficacy ? Biol Psychiatry 1984 : 19 : 1551 – 1564.en_US
dc.identifier.citedreferenceLevy A., Zohar J., Belmaker R H. The effect of chronic lithium pretreatment in rat brain muscarinic receptor regulation. Neuropharmacology 1982 : 21 : 1199 – 1201.en_US
dc.identifier.citedreferenceDilsaver S C. Pharmacologic induction of cholinergic system supersensitivity in affective disorders research. J Clin Psychophamacology ( in press, 1986 ).en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0447.1986.tb06229.x.pdf
Size:
386.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.